Table 1.
Characteristic | n (%) |
---|---|
| |
Study site | |
Portland, OR | 1665 (34) |
Honolulu, HI | 366 (8) |
Detroit, MI | 1710 (35) |
Danville, PA | 1133 (23) |
| |
Age group | |
18–34 years | 221 (5) |
35–54 years | 904 (19) |
55–64 years | 2332 (48) |
≥65 years | 1417 (29) |
| |
Male | 2734 (56) |
| |
Race/ethnicity | |
Black | 929 (19) |
White | 3540 (73) |
Asian/Other | 405 (8) |
Hispanic | 225 (4.6) |
| |
Privately insured | 2677 (55) |
| |
Married | 2430 (50) |
| |
Currently employed | 2255 (46) |
| |
Current smoker | 1689 (35) |
| |
Reported history of injection drug use from survey | 2456 (52) |
| |
Ever received HCV treatment | 2404 (49) |
| |
Presence of decompensated liver disease22 | 1169 (24) |
| |
Charleson comorbidity score23 ≥ 2 (omitting liver disease) | 743 (15) |